BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee JW, Choi JS, Lyu J, Lee SM. Prognostic significance of 18F-fluorodeoxyglucose uptake of bone marrow measured on positron emission tomography in patients with small cell lung cancer. Lung Cancer 2018;118:41-7. [PMID: 29572001 DOI: 10.1016/j.lungcan.2018.01.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Caballero Vázquez A, Garcia Flores P, Romero Ortiz A, García Del Moral R, Alcázar-Navarrete B. Small cell lung cancer: Recent changes in clinical presentation and prognosis. Clin Respir J 2020;14:222-7. [PMID: 31802620 DOI: 10.1111/crj.13119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Bang JI, Yoon HJ, Kim BS. Clinical utility of FDG uptake within reticuloendothelial system on F-18 FDG PET/CT for prediction of tumor recurrence in breast cancer. PLoS One 2018;13:e0208861. [PMID: 30532215 DOI: 10.1371/journal.pone.0208861] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
3 Pijl JP, Kwee TC, Slart RHJA, Yakar D, Wouthuyzen-Bakker M, Glaudemans AWJM. Clinical implications of increased uptake in bone marrow and spleen on FDG-PET in patients with bacteremia. Eur J Nucl Med Mol Imaging 2021;48:1467-77. [PMID: 33106925 DOI: 10.1007/s00259-020-05071-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lee JW, Park SH, Ahn H, Lee SM, Jang SJ. Predicting Survival in Patients with Pancreatic Cancer by Integrating Bone Marrow FDG Uptake and Radiomic Features of Primary Tumor in PET/CT. Cancers (Basel) 2021;13:3563. [PMID: 34298775 DOI: 10.3390/cancers13143563] [Reference Citation Analysis]
5 Lee JW, Ban MJ, Park JH, Lee SM. Effect of F-18 Fluorodeoxyglucose Uptake by Bone Marrow on the Prognosis of Head and Neck Squamous Cell Carcinoma. J Clin Med 2019;8:E1169. [PMID: 31382679 DOI: 10.3390/jcm8081169] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
6 Lee JW, Kim SY, Han SW, Lee JE, Lee HJ, Heo NH, Lee SM. [18F]FDG uptake of bone marrow on PET/CT for predicting distant recurrence in breast cancer patients after surgical resection. EJNMMI Res 2020;10:72. [PMID: 32607957 DOI: 10.1186/s13550-020-00660-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Seban RD, Rouzier R, Latouche A, Deleval N, Guinebretiere JM, Buvat I, Bidard FC, Champion L. Total metabolic tumor volume and spleen metabolism on baseline [18F]-FDG PET/CT as independent prognostic biomarkers of recurrence in resected breast cancer. Eur J Nucl Med Mol Imaging 2021. [PMID: 33774685 DOI: 10.1007/s00259-021-05322-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Li TC, Wang LL, Liu BL, Hong JJ, Xu NN, Tang K, Zheng XW. Association between bone marrow fluorodeoxyglucose uptake and recurrence after curative surgical resection in patients with T1-2N0M0 lung adenocarcinoma: a retrospective cohort study. Quant Imaging Med Surg 2020;10:2285-96. [PMID: 33269227 DOI: 10.21037/qims-19-962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Kim CG, Hwang SH, Kim KH, Yoon HI, Shim HS, Lee JH, Han Y, Ahn BC, Hong MH, Kim HR, Cho BC, Cho A, Lim SM. Predicting treatment outcomes using 18F-FDG PET biomarkers in patients with non-small-cell lung cancer receiving chemoimmunotherapy. Ther Adv Med Oncol 2022;14:17588359211068732. [PMID: 35035536 DOI: 10.1177/17588359211068732] [Reference Citation Analysis]
10 Schiano C, Soricelli A, De Nigris F, Napoli C. New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions. Expert Rev Clin Immunol 2019;15:289-301. [PMID: 30570412 DOI: 10.1080/1744666X.2019.1561283] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.7] [Reference Citation Analysis]
11 Lee SM, Lee JW, Lee J, Jo IY, Jang SJ. Prognostic Value of Dual-Time-Point [18F]FDG PET/CT for Predicting Distant Metastasis after Treatment in Patients with Non-Small Cell Lung Cancer. JPM 2022;12:592. [DOI: 10.3390/jpm12040592] [Reference Citation Analysis]
12 Jeong SY, Kim SJ, Pak K, Lee SW, Ahn BC, Lee J. Prognostic value of 18F-fluorodeoxyglucose bone marrow uptake in patients with solid tumors: A meta-analysis. Medicine (Baltimore) 2018;97:e12859. [PMID: 30412079 DOI: 10.1097/MD.0000000000012859] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 Hua T, Zhou W, Zhou Z, Guan Y, Li M. Heterogeneous parameters based on 18F-FET PET imaging can non-invasively predict tumor grade and isocitrate dehydrogenase gene 1 mutation in untreated gliomas. Quant Imaging Med Surg 2021;11:317-27. [PMID: 33392031 DOI: 10.21037/qims-20-723] [Cited by in F6Publishing: 1] [Reference Citation Analysis]